Imperial College London
Alternate

ProfessorSejalSaglani

Faculty of Medicine, National Heart & Lung Institute

Professor of Paediatric Respiratory Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 3167s.saglani

 
 
//

Location

 

112Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Bloom:2019:10.1183/13993003.02130-2018,
author = {Bloom, C and Saglani, S and Feary, J and Jarvis, D and Quint, J},
doi = {10.1183/13993003.02130-2018},
journal = {European Respiratory Journal},
pages = {1--8},
title = {Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population based cohort 2006 to 2016},
url = {http://dx.doi.org/10.1183/13993003.02130-2018},
volume = {53},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BACKGROUND:Asthma is the most common respiratory disorder in the UK, yet we have incomplete knowledge on the prevalence of current disease, treatment and exacerbations.METHODS:We used UK electronic healthcare records, 2006 to 2016, to estimate the prevalence of current asthma by year, gender and age (<5, 5-11, 12-17, 18-24, 25-54 and ≥55 years), and the proportion prescribed inhaled corticosteroids (ICS) and additional asthma-therapy, treated for exacerbations and other asthma care markers. RESULTS:Overall current asthma prevalence was 6.5% in 2016 (7.2% in 2006). Prevalence fell in those under 45 years. The lowest prevalence and largest absolute decrease was in children under 5-years. In 2016, 80% of current asthma patients were managed on ICS, (65% in 2006); this increase occurred in all ages, primarily due to an increase in low-dose ICS. During this time there was an increase in all age-groups in the proportion prescribed additional asthma-therapy, treated for an exacerbation within primary care, given an annual asthma review or management plan. Hospitalised exacerbations showed minimal change over time.CONCLUSION:Asthma remains highly prevalent and a significant healthcare burden. In those with a diagnosis, there was an increase in ICS prescriptions and treatment of exacerbations across all age-groups. This may reflect a trend towards more aggressive asthma management within primary care. An apparent decline in prevalence was observed in those aged under 45 years, particularly in children under 5 years.
AU  - Bloom,C
AU  - Saglani,S
AU  - Feary,J
AU  - Jarvis,D
AU  - Quint,J
DO  - 10.1183/13993003.02130-2018
EP  - 8
PY  - 2019///
SN  - 0903-1936
SP  - 1
TI  - Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population based cohort 2006 to 2016
T2  - European Respiratory Journal
UR  - http://dx.doi.org/10.1183/13993003.02130-2018
UR  - https://erj.ersjournals.com/content/53/4/1802130
UR  - http://hdl.handle.net/10044/1/66359
VL  - 53
ER  -
Download